Novel targets and techniques in imidazoline receptor research

Annals of the New York Academy of Sciences

Volumn 881, Issue , 1999, Pages 301-312

  Musgrave, Ian F ^a   Hughes, Richard A ^a,b  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; IMIDAZOLINE RECEPTOR; NICOTINIC RECEPTOR; PHENCYCLIDINE; PHOSPHOLIPASE C;

BINDING SITE; CELL MEMBRANE; CELL STRAIN; CHEMICAL STRUCTURE; CONFERENCE PAPER; MOLECULAR MODEL; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

BOVINAE;

EID: 0032802434     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09375.x     Document Type: Conference Paper

References (51)

1. Ernsberger, P., J. E. Friedman & R. J. Koletsky. 1997. The I1-imidazoline receptor: From binding site to therapeutic target in cardiovascular disease. J. Hypertens. 15: S9-23.
2. Bousquet, P. 1997. Imidazoline receptors. Neurochem. Int. 30: 3-7.
3. Head, G. A., S. L. Burke & C. K. Chan. 1997. Central imidazoline receptors and centrally acting anti-hypertensive agents. Clin. Exp. Hypertens. 19: 591-605.
4. Guyenet, P. G. 1997. Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites? Am. J. Physiol. 273: R1580-R1584.
5. Eglen, R. M., A. L. Hudson, D. A. Kendall, D. J. Nutt, N. G. Morgan, V. G. Wilson & M. Dillon. 1998. Seeing through a glass darkly: Casting light on imidazoline i sites. Trends Pharmacol. Sci. 19: 381-390.
6. Glavin, G. B. & D. D. Smyth. 1995. Effects of the selective I1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats. Br. J. Pharmacol. 114: 751-754.
7. Smyth, D. D., F. K. Darkwa & S. B. Penner. 1995. Imidazoline receptors and sodium excretion in the rat kidney. Ann. N.Y. Acad. Sci. 763: 340-352.
8. Piletz, J. E., H. Zhu & D. N. Chikkala. 1996. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J. Pharmacol. Exp. Ther. 279: 694-702.
9. Ernsberger, P. & I. H. Shen. 1997. Membrane localization and guanine nucleotide sensitivity of medullary I1-imidazoline binding sites. Neurochem. Int. 30: 17-23.
10. Molderings, G. J., D. Moura, K. Fink, H. Bönisch & M. Göthert. 1993. Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes. Naunyn-Schmiedeberg's. Arch. Pharmacol. 348: 70-76.
11. Greney, H., M. Dontenwill, G. Bricca, A. Belcourt & P. Bousquet. 1995. Human cerebral imidazoline binding sites. Further biochemical investigations. Ann. N.Y. Acad. Sci. 763: 523-525.
12. Ivanov, T. R., H. Zhu, S. Regunathan, D. J. Reis, M. Dontenwill, C. Vonthron, P. Bousquet & J. E. Piletz. 1998. Co-detection by two imidazoline receptor protein antisera of a novel 85 kilodalton protein. Biochem. Pharmacol. 55: 649-655.
13. Garcia-Sevilla, J. A., P. V. Escriba, M. Sastre, C. Walzer, X. Busquets, G. Jaquet, D. J. Reis & J. Guimon. 1996. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch. Gen. Psychiatry 53: 803-810.
14. Regunathan, S., M. J. Evinger, M. P. Meeley & D. J. Reis. 1991. Effects of clonidine and other imidazole-receptor binding agents on second-messenger systems and calcium influx in bovine adrenal chromaffin cells. Biochem. Pharmacol. 42: 2011-2018.
15. Regunathan, S., M. P. Meeley & D. J. Reis. 1990. Effect of clonidine on second messenger systems in rat adrenal gland. Life Sci. 47: 2127-2133.
16. Regunathan, S., S. Bramwell & D. J. Reis. 1995. Effects of rilmenidine on signal transduction mechanisms associated with alpha 2-adrenergic and imidazoline receptors in brain. Ann. N.Y. Acad. Sci. 763: 290-294.
17. Regunathan, S. & D. J. Reis. 1994. Effects of moxonidine, an imidazoline antihypertensive agent, on second messenger systems in rat brain. Eur. J. Pharmacol. 269: 273-276.
18. Musgrave, I. F., D. Krautwurst & G. Schultz. 1996. Imidazoline binding sites and signal transduction pathways. Clin. Exp. Pharmacol. Physiol. 23: 990-994.
19. Musgrave, I. F., D. Krautwurst, J. Hescheler & G. Schultz. 1995. Clonidine and cirazoline inhibit activation of nicotinic channels in PC-12 cells. Ann. N.Y. Acad. Sci. 763: 272-282.
20. 2A-adrenoceptors mediate activation of nonselective cation channels via Gi-proteins in human erythroleukaemia (HEL) cells. No evidence for a functional role of imidazoline receptors in modulating calcium. Biochem. Pharmacol. 49: 187-196.
21. 1-imidazoline receptors in PC12 cells and rostral ventrolateral medulla. Brain Res. 749: 335-339.
22. 1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells. Mol. Pharmacol. 49: 668-675.
23. 1-imidazoline receptors using microphysiometry and molecular modelling. J. Autonom. Nerv. Syst. 72: 137-146.
24. 2 binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 354: 245-252.
25. 2-imidazoline binding sites to inhibitory effects of imidazolines on ligand-gated ion channels. An investigation in the adrenal medulla and in neuroblastoma cells. Ann. N.Y. Acad. Sci. 763: 420-432.
26. Shepherd, R. M., M. N. Hashmi, C. Kane, P. E. Squires & M. J. Dunne. 1996. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: Implications for stimulus-response coupling of insulin release. Br. J. Pharmacol. 119: 911-916.
27. Dunne, M. J. 1991. Block of ATP-regulated potassium channels by phentolamine and other α-adrenoceptor antagonists. Br. J. Pharmacol. 103: 1847-1850.
28. Olmos, G., J. Ribera & J. A. Garcia-Sevilla. 1996. Imidazoli(di)ne compounds interact with the phencyclidine site of NMDA receptors in the rat brain. Eur. J. Pharmacol. 310: 273-276.
29. Lei, L., P. L. Vaghy, M. Slavica, J. De Los Angeles, B. Smith, D. D. Miller & D. R. Feller. 1998. Activation of L-type calcium channel by tolazoline derivatives: Role of isothiocyanate moiety. J. Cardiovasc. Pharmacol. 31: 721-733.
30. Ohara Imaizumi, M. & K. Kumakura. 1992. Effects of imidazole compounds on catecholamine release in adrenal chromaffin cells. Cell Mol. Neurobiol. 12: 273-283.
31. 2-Adrenoceptors do not regulate catecholamine secretion by bovine adrenal medullary cells: a study with clonidine. Mol. Pharmacol. 29: 134-141.
32. Chan, S. L. & N. G. Morgan. 1998. Sigma receptor ligands and imidazoline secretagogues mediate their insulin secretory effects by activating distinct receptor systems in isolated islets. Eur. J. Pharmacol. 350: 267-272.
33. Hirose, H., Y. Seto, H. Maruyama, K. Dan, K. Nakamura & T. Saruta. 1997. Effects of alpha 2-adrenergic agonism, imidazolines, and G-protein on insulin secretion in beta cells. Metabolism 46: 1146-1149.
34. Mourtada, M., C. A. Brown, S. A. Smith, V. Piercy, S. L. Chan & N. G. Morgan. 1997. Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion. Br. J. Pharmacol. 121: 799-805.
35. Berdeu, D., R. Gross, R. Puech, M. M. Loubatieres-Mariani & G. Bertrand. 1995. Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat. Eur. J. Pharmacol. 275: 91-98.
36. 2-imidazoline receptors. Ann. N.Y. Acad. Sci. 763: 374-376.
37. 2 sites. Ann. N.Y. Acad. Sci. 763: 153-156.
38. Chan, S. L., A. L. Pallett, J. Clews, C. A. Ramsden & N. G. Morgan. 1997. Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors. Eur. J. Pharmacol. 323: 241-244.
39. Rustenbeck, I., C. Herrmann, P. Ratzka & A. Hasselblatt. 1997. Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 356: 410-417.
40. Rogawski, M. A., M. Pieniek, S. Suzuki & J. M. Ffrench-Mullen. 1988. Phencyclidine selectively blocks the sustained voltage-dependent potassium conductance in PC12 cells. Brain Res. 456: 38-48.
41. Rothman S. 1988. Noncompetitive N-methyl-D-aspartate antagonists affect multiple ionic currents. J. Pharmacol. Exp. Ther. 246: 137-142.
42. Weinstein, H., S. Maayani & B. Pazhenchevsky. 1983. Multiple actions of phencyclidine: discriminant structure-activity relationships from molecular conformations and assay conditions. Fed. Proc. 42: 2574-2578.
43. Albuquerque, E. X., J. W. Daly & J. E. Warnick. 1988. Macromolecular sites for specific neurotoxins and drugs on chemosensitive synapses and electrical excitation in biologic membranes. Ion Channels 1: 95-162.
44. Cull Candy, S. G., A. Mathie & D. A. Powis. 1988. Acetylcholine receptor channels and their block by clonidine in cultured bovine chromaffin cells. J. Physiol. Lond. 402: 255-278.
45. ATP channels is mediated by Kir6.2. Proc. Natl. Acad. Sci. USA 94: 11716-11720.
46. 2 imidazoline and sigma binding sites in the rat and human stomach. J. Pharmacol. Exp. Ther. 285: 170-177.
47. Moebius, F. F., J. Striessnig & H. Glossmann. 1997. The mysteries of sigma receptors: New family members reveal a role in cholesterol synthesis. Trends. Pharmacol. Sci. 18: 67-70.
48. Pitchford, S., K. De Moor & B. S. Glaeser. 1995. Nerve growth factor stimulates rapid metabolic responses in PC12 cells. Am. J. Physiol. 268: C936-C943.
49. McConnell H. M., J. C. Owicki, J. W. Parce, D. L. Miller, G. T. Baxter, H. G. Wada & S. Pitchford. 1992. The cytosensor microphysiometer: Biological applications of silicon technology. Science 257: 1906-1912.
50. Evinger, M. J., P. Ernsberger, S. Regunathan & D. J. Reis. 1995. Regulation of phenylethanolamine N-methyltransferase gene expression by imidazoline receptors in adrenal chromaffin cells. J. Neurochem. 65: 988-997.
51. Pigini, M., P. Bousquet, A. Carotti, M. Dontenwill, M. Giannella, R. Moriconi, A. Piergentili, W. Quaglia, S. K. Tayebati & L. Brasili. 1997. Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity. Bioorg. Med. Chem. 5: 833-841.